Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02282111 · ClinicalTrials.gov registry record · NA
EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors
A NA study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT02282111: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT02282111 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02282111, a NA study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
This is a single-blinded randomized control trial trying to compare the effectiveness of diagnosis between two techniques employed in tissue sampling for subepithelial tumors (SETs) of the gastrointestinal tract. Over 2 years, patients having SET will be randomized to either get the EUS-guided core needle biopsy (EUS-CNB) or EUS-guided single-incision with needle knife (SINK) technique. This is of grave importance because the diagnosis of the myriad types of SETs is made histologically requiring a good sample.
Primary Outcome
Diagnostic accuracy is defined as the percentage of true positive and true negative biopsy specimens combined divided by total number of specimens
Interventions
- DEVICE 22-gauge Procore needle (ProCore, Cook Medical Inc., Winston-Salem, NC)
- DEVICE conventional needle-knife sphincterotome (Microknife XL; Boston Scientific Inc, Natick, Mass)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2014-07 |
| Est. Completion | 2017-11 |
| Phase | NA |
Why NCT02282111 stopped before completion
NCT02282111 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which 22-gauge Procore needle (ProCore, Cook Medical Inc., Winston-Salem, NC) is the first listed.
NCT02282111 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02282111 about?
NCT02282111 is a clinical study titled "EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors". This is a single-blinded randomized control trial trying to compare the effectiveness of diagnosis between two techniques employed in tissue sampling for subepithelial tumors (SETs) of the gastrointestinal tract. Over 2 years, patients having SET will be randomized to either get the EUS-guided core ...
What is the current status of trial NCT02282111?
This trial is currently terminated. It is a NA study. The enrollment target is 56 participants. The study started on 2014-07. Estimated completion is 2017-11.
What interventions are being tested in trial NCT02282111?
The interventions under investigation include: 22-gauge Procore needle (ProCore, Cook Medical Inc., Winston-Salem, NC) (DEVICE), conventional needle-knife sphincterotome (Microknife XL; Boston Scientific Inc, Natick, Mass) (DEVICE).
Who is sponsoring clinical trial NCT02282111?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02282111's enrollment target sits among peer trials
56 1262nd of 2000 higher than 737 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia